United States· US:16110-915_ee97b76e-eb11-4165-ae85-1277eba9ff35
TAZORAC
A tazarotene product containing tazarotene, registered in United States by Almirall, LLC. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Tazarotene is registered in 4 of 19 countries.
Countries holding a registration under ATC D05AX05 (tazarotene), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Tazarotene · ATC D05AX05
4 / 19 countries
- Canada
- Finlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TAZAROTENE
- Manufacturer
- Almirall, LLC
- Country
- United States (US)
- ATC code
- D05AX05
- ATC class
- Tazarotene
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1116110915301 TUBE in 1 CARTON (16110-915-30) / 30 g in 1 TUBE
- ndc1116110915601 TUBE in 1 CARTON (16110-915-60) / 60 g in 1 TUBE
- ndc1116110-915-60
- ndc1116110-915-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
35 interactions on record for tazarotene.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tazarotene · interactions on record
35 records
- 1 severe
- 6 moderate
- 28 info
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- Salicylic acidD01AE12moderate
- IsotretinoinD10AD04moderate
- IsotretinoinD10BA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tazarotene in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cc63172f-399b-4bf0-af58-4422a0a1dfe3 GET /v1/drugs/cc63172f-399b-4bf0-af58-4422a0a1dfe3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "CUTANEOUS",
"source": "ndc",
"strength": ".05",
"substance": "TAZAROTENE",
"productndc": "16110-915",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "mg/g",
"application_number": "NDA021184",
"marketing_category": "NDA"
}See everything about tazarotene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.